Late immune dysregulation following allogeneic hematopoietic cell transplantation (HCT) is
known as chronic graft-versus-host disease (GVHD), which is a major cause of mortality and …

Recently, Pidala and Anasetti [1] presented a review on glucocorticoid-refractory acute graft-
versus-host disease (aGVHD), which included options for salvage therapies and future …

Background Extracorporeal photopheresis (ECP) is an important cell‐based therapy for graft‐
versus‐host disease (GVHD); however, the blood volume required per treatment to achieve …

Graft-versus-host disease (GVHD) remains a major challenge for progress in allogeneic
hematopoietic cell transplantation. Steroids continue to be the most effective firstline therapy …

Extracorporeal photopheresis (ECP) has become a recognised treatment for steroid-
refractory chronic GVHD (cGVHD), but the optimal frequency and duration of treatment are …

Graft versus host disease (GVHD), whether acute or chronic, is a frightening complication of
bone marrow allografts—indeed in many cases it can be life threatening. In chronic GVHD …

BACKGROUND Extracorporeal photopheresis (ECP) has been increasingly used as a
second‐line therapy for graft‐versus‐host disease (GVHD) but there is no consensus …

BACKGROUND Extracorporeal photopheresis (ECP) has demonstrated efficacy as second‐
line treatment for steroid‐refractory (SR) acute graft‐versus‐host disease (aGVHD). The aim …

Chronic Graft versus Host Disease (cGvHD) is an important cause of late non-relapse
morbidity and mortality following allogeneic hemopoietic stem cell transplantation (allo …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …